Vanguards of Health Care by Bloomberg Intelligence

Bloomberg
  • 0,0 (0)
  • INVESTEREN
  • TWEEWEKELIJKS
Vanguards of Health Care by Bloomberg Intelligence

Vanguards of Health Care is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

  1. 27 FEB

    Absci Leveraging Gen AI for Best-in-Class Antibodies

    “As US biotech companies, how do we continue to differentiate and create novel breakthrough assets? I think it’s leveraging AI,” said Sean McClain, founder and CEO of Absci. McClain and Christian Stegmann, senior vice president of drug creation, sit down with Bloomberg Intelligence analyst Andrew Galler in this episode of the Vanguards of Health Care podcast to discuss Absci’s generative AI platform and developing best-in-class biologics. See omnystudio.com/listener for privacy information.

    58 min

  2. 20 FEB

    How Capital Rx is Fixing America’s Broken Drug Pricing

    "The mission of Capital Rx is to give our country the infrastructure we need for the healthcare we deserve." AJ Loiacono, CEO and co-founder of Capital Rx, shares with Bloomberg Intelligence analyst Jonathan Palmer how his company is reshaping the pharmacy benefit management (PBM) industry by eliminating hidden costs and conflicts of interest. He explains how traditional PBMs profit from inflated drug prices, creating a system where the most expensive drugs are preferred over more affordable alternatives. Capital Rx aims to disrupt this model by using technology to reduce administrative costs and promote transparency. The discussion also covers regulatory reform and how AI-driven claims processing, with a unified approach to medical and pharmacy benefits, could unlock massive cost savings. See omnystudio.com/listener for privacy information.

    55 min

  3. 13 FEB

    Eleos Health's AI-Powered Platform is Reshaping Behavioral Care

    "The conversation is the treatment in behavioral health, but clinicians spend too much time documenting instead of caring,” says Alon Joffe, CEO and cofounder of Eleos Health, in this episode of the Vanguards of Health Care podcast. Joffe joins Bloomberg Intelligence analyst Jonathan Palmer to discuss how Eleos is revolutionizing behavioral health care with AI-driven solutions that reduce administrative burdens by 80% while enhancing clinical outcomes. He shares how Eleos leverages multimodal AI to automate documentation and improve decision-making, enabling clinicians to provide better care. The conversation explores Eleos’ expansion into psychiatry, substance-use treatment and long-term care, as well as its vision to become the AI-native operating system for compassionate care. See omnystudio.com/listener for privacy information.

    40 min

  4. 6 FEB

    Truveta Unlocks the Power of Data to Help Solve Industry's Biggest Challenges

    “There’s no digital feedback loop in health care, you have it in Tesla, in Netflix, in Amazon — but not in the industry that impacts every life,” Terry Myerson, CEO of Truveta, explains to Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. Myerson joins BI analyst Jonathan Palmer to discuss Truveta’s mission to aggregate and analyze health data across 30 major US health systems, covering one-third of Americans. He details the company’s work in regulatory-grade safety and efficacy research, the launch of the Truveta Genome Project with partners like Regeneron and Illumina, and the power of AI-driven insights to accelerate medical discovery. The conversation explores Truveta’s efforts to address data fragmentation, privacy, and interoperability challenges that must be solved to revolutionize patient care and life sciences. See omnystudio.com/listener for privacy information.

    44 min

  5. 30 JAN

    Insights from GSK's Chief Scientist on the Role of Technology in R&D

    "We talk about the S-curve for technology and in the past we've said it can be 10 or 20 years before you reach the top. I think what's going to be really different about AI is that time frame is going to be massively compressed," Dr. Tony Wood, Chief Scientific Officer at GSK, explains to Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. Dr. Wood joins BI analyst Sam Fazeli to address the disconnect between market expectations for its future drugs in the context of GSK's R&D strategy and technology leverage. The company has five potential new drug approvals in 2025 and sees its early stage investments in AI and ML holding huge potential to catalyze future drug discovery and development. See omnystudio.com/listener for privacy information.

    47 min

  6. 23 JAN

    LRVHealth Looks to the Next Chapter of Health Care's Evolution Driven by Unique Partnerships

    “We sit at the intersection of those large-scale incumbents and entrepreneurs, to help bridge the gap,” Josh Flum, managing partner at LRVHealth, tells Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. Flum joins BI analyst Jonathan Palmer to discuss how LRV’s purpose-built model looks to identify and capitalize on durable long-term trends emerging in health care. With only strategic investors as limited partners, LRV believes it has a differentiated perspective on where the market is headed. The conversation delves into the evolution of pharmacy services and why it’s important to build high-performing teams. The exchange wraps up with the state of the IPO market and key takeaways from the JPMorgan Healthcare conference. See omnystudio.com/listener for privacy information.

    54 min

  7. 16 JAN

    Soda Health's Tech Forward Approach to Optimizing Benefits Starts With a Smart Platform

    “The average benefit value for supplemental benefits was about $155 per member. Five years later, it was over $1,500 per member,” Robby Knight, CEO and cofounder of Soda Health, tells Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. Knight joins BI analyst Jonathan Palmer for a wide-ranging discussion on the rapid evolution of the supplemental-benefits market and the challenges Soda faced in building in a new platform that creates incentives for members, retail partners and plan sponsors. The conversation touches on why Medicare Advantage plans were in an arms race to offer unsustainable benefits, why the correction is an opportunity for the company and how the future will bring optimized benefits at the member level. See omnystudio.com/listener for privacy information.

    54 min

  8. 05-12-2024

    Sequel Develops Novel Insulin Delivery System in Next Wave of Diabetes Innovation

    Sequel is combining the experience of its four co-founders to develop the next generation of insulin pumps, aiming to provide better delivery capabilities, CEO Alan Lotvin tells Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Lotvin sits down with BI analyst Matt Henriksson for an in-depth interview on the path insulin pumps have taken over the past 50 years to close in on a truly automated delivery system. They also discuss Sequel’s development of its twiist delivery system, designed to better titrate insulin injected into the body, and its strategy for commercial launch in 2025. See omnystudio.com/listener for privacy information.

    46 min
Bekijk alles (75)

Info

Vanguards of Health Care is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

Informatie

  • Maker
    Bloomberg
  • Jaren actief
    2023 - 2025
  • Afleveringen
    75
  • Beoordeling
    Veilig
  • Copyright
    © 2025 Bloomberg
  • Website van aflevering
    Vanguards of Health Care by Bloomberg Intelligence
  • Provider

    Bloomberg L.P. heeft zich geïdentificeerd als een handelaar van deze podcast en heeft bevestigd dat dit product of deze dienst voldoet aan de wetgeving van de Europese Unie. Adres 731 Lexington Ave New York New York 10022-1331 Verenigde Staten Telefoonnummer +1 9177273274 E-mail dbennett64@bloomberg.net

Suggesties voor jou

Om naar expliciete afleveringen te luisteren, moet je inloggen

Blijf op de hoogte van dit programma

Log in of meld je aan om programma’s te volgen, afleveringen te bewaren en de laatste updates te ontvangen.
Kies een land of regio

Afrika, Midden-Oosten en India

Azië, Stille Oceaan

Europa

Latijns-Amerika en het Caribisch gebied

Verenigde Staten en Canada